JFROG LTD (FROG)

IL0011684185 - Common Stock

33.1  +0.21 (+0.64%)

After market: 33.3 +0.2 (+0.6%)

Fundamental Rating

5

FROG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. While FROG has a great health rating, there are worries on its profitability. FROG shows excellent growth, but is valued quite expensive already.



3

1. Profitability

1.1 Basic Checks

In the past year FROG was profitable.
FROG had a positive operating cash flow in the past year.
FROG had negative earnings in each of the past 5 years.
In the past 5 years FROG always reported a positive cash flow from operatings.

1.2 Ratios

FROG has a Return On Assets of -4.94%. This is comparable to the rest of the industry: FROG outperforms 54.71% of its industry peers.
FROG has a Return On Equity (-6.96%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.94%
ROE -6.96%
ROIC N/A
ROA(3y)-8.06%
ROA(5y)-5.56%
ROE(3y)-11.17%
ROE(5y)-7.8%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 78.61%, FROG is in the better half of the industry, outperforming 77.90% of the companies in the same industry.
In the last couple of years the Gross Margin of FROG has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for FROG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.27%

8

2. Health

2.1 Basic Checks

FROG does not have a ROIC to compare to the WACC, probably because it is not profitable.
FROG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FROG has been increased compared to 5 years ago.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

FROG has an Altman-Z score of 7.68. This indicates that FROG is financially healthy and has little risk of bankruptcy at the moment.
FROG has a Altman-Z score of 7.68. This is in the better half of the industry: FROG outperforms 79.71% of its industry peers.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.68
ROIC/WACCN/A
WACC9.91%

2.3 Liquidity

A Current Ratio of 2.60 indicates that FROG has no problem at all paying its short term obligations.
FROG has a Current ratio of 2.60. This is in the better half of the industry: FROG outperforms 72.83% of its industry peers.
A Quick Ratio of 2.60 indicates that FROG has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.60, FROG is doing good in the industry, outperforming 72.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.6

8

3. Growth

3.1 Past

FROG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 510.00%, which is quite impressive.
Looking at the last year, FROG shows a very strong growth in Revenue. The Revenue has grown by 25.06%.
The Revenue has been growing by 40.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)510%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q166.67%
Revenue 1Y (TTM)25.06%
Revenue growth 3Y32.39%
Revenue growth 5Y40.68%
Revenue growth Q2Q25.67%

3.2 Future

Based on estimates for the next years, FROG will show a very strong growth in Earnings Per Share. The EPS will grow by 23.42% on average per year.
FROG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.39% yearly.
EPS Next Y19.9%
EPS Next 2Y18.7%
EPS Next 3Y23.57%
EPS Next 5Y23.42%
Revenue Next Year23.48%
Revenue Next 2Y22.08%
Revenue Next 3Y22.46%
Revenue Next 5Y22.39%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 54.26, the valuation of FROG can be described as expensive.
Based on the Price/Earnings ratio, FROG is valued a bit cheaper than 61.96% of the companies in the same industry.
FROG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.60.
The Price/Forward Earnings ratio is 46.06, which means the current valuation is very expensive for FROG.
The rest of the industry has a similar Price/Forward Earnings ratio as FROG.
FROG is valuated expensively when we compare the Price/Forward Earnings ratio to 20.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 54.26
Fwd PE 46.06

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, FROG is valued a bit cheaper than 67.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.76
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates FROG does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as FROG's earnings are expected to grow with 23.57% in the coming years.
PEG (NY)2.73
PEG (5Y)N/A
EPS Next 2Y18.7%
EPS Next 3Y23.57%

0

5. Dividend

5.1 Amount

FROG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JFROG LTD

NASDAQ:FROG (5/17/2024, 7:00:01 PM)

After market: 33.3 +0.2 (+0.6%)

33.1

+0.21 (+0.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 54.26
Fwd PE 46.06
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.94%
ROE -6.96%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 78.61%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.6
Quick Ratio 2.6
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)510%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y19.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.06%
Revenue growth 3Y32.39%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y